US Health Secretary Kennedy distances himself from FDA’s Replimune cancer drug rejection

Investing.com Gold reports: US Health Secretary Kennedy distances himself from FDA’s Replimune cancer drug rejection. Full body text was unavailable at ingest time, so this brief is based on headline context.